Filana Therapeutics Inc (FLNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 30 | -2,613 | -2,222 | -1,407 | -207 |
| Depreciation Amortization | 35 | 163 | 128 | 93 | 53 |
| Income taxes - deferred | N/A | 4 | N/A | N/A | N/A |
| Accounts receivable | N/A | 7,114 | 6,474 | 6,275 | N/A |
| Accounts payable and accrued liabilities | 38 | -643 | -551 | -503 | -671 |
| Other Working Capital | -451 | 6,175 | 5,626 | 5,072 | 4,458 |
| Other Operating Activity | -1,722 | -10,460 | -8,906 | -7,808 | -364 |
| Operating Cash Flow | $-2,070 | $-260 | $549 | $1,722 | $3,269 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,705 | 59,903 | 57,400 | 47,400 | 42,402 |
| Investing Cash Flow | $2,705 | $59,903 | $57,400 | $47,400 | $42,402 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 9,042 | 8,962 | 8,910 | 4,425 |
| Other Financing Activity | 0 | -339 | 0 | 0 | 0 |
| Financing Cash Flow | $0 | $8,703 | $8,962 | $8,910 | $4,425 |
| Beginning Cash Position | 73,144 | 4,798 | 4,798 | 4,798 | 4,798 |
| End Cash Position | 73,779 | 73,144 | 71,709 | 62,830 | 54,894 |
| Net Cash Flow | $635 | $68,346 | $66,911 | $58,032 | $50,096 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,070 | -260 | 549 | 1,722 | 3,269 |
| Free Cash Flow | -2,070 | -260 | 549 | 1,722 | 3,269 |